SynthaMASIN – Exemestane 50x25mg/tab – SynthaPharma

80

Exemestane is a competitive inhibitor of peripheral estrogen receptors. Initially, Exemestane was used to treat cancer in women. But today, Exemestane is much more popular in the field of sports and bodybuilding in particular.

Description

Exemestane, like Arimidex (Anastrozole), is an aromatase inhibitor and works to stop the conversion of testosterone to estrogen. Exemestane also increases the testosterone level of 60%, thus speeding up the restoration of testosterone.

Action of Exemestane

  • Increased strength.
  • Increased hardness and texture of the musculature.
  • Increased muscle mass.
  • Fight against fat deposits.
  • Prevention against feminization.
  • Improved liver function.

By taking 20-25 mg per day, Exemestane can block estrogen enzymes at 65% and increase testosterone production substantially. The sole use of Exemestane (2 weeks of intake) is not recommended and should always be combined with a SERM like Nolvadex or Clomid in PCT.

According to studies, Exemestane has a good influence on bone mineral content and lipid profile.

Reviews

There are no reviews yet.


Be the first to review “SynthaMASIN – Exemestane 50x25mg/tab – SynthaPharma”

Only this month of October 2024, FREE SHIPPING on NEW SynthaPharma Stock

For all orders over 200€/$

Using coupon code: SYNTHA

SYNTHAPHARMA Stock

Delivery cost :

– Europe: 20€ = 22$
- UNITED STATES : 30€ = 33$

+ Option 2 "Guarantee": The warranty protects you against breakage, loss or seizure of your package in customs. It represents only 10% of the total of your order. Like 95 % of our customers trusting our insurance, opt for security!

Shipping only to Europe (Spain, France, Czech Republic, Italy, Belgium, Portugal, etc.) and the United States.

• Package Shipping: within 72 hours (excluding weekends) after the validation of your payment.
• Transit time: 2-3 days for Europe, and 10-14 days for the United States.
• Sending of the postal tracking code: 2 to 3 days after the package is shipped.